Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jeffrey W Meeusen

Showing results (1-10 of 67) with videos related to

Pageof 7
Sort By:
Clinical Chemistry|February 27, 2020
Apolipoprotein B or Low-Density Lipoprotein Cholesterol: Is It Time for a Twenty-First-Century Lipid Marker?Jeffrey W Meeusen
Clinical Chemistry|January 6, 2018
Comparing Measures of HDL: On the Right Path with the Wrong MapJeffrey W Meeusen
Clinical Chemistry|June 8, 2021
Is Small Dense LDL a Highly Atherogenic Lipid or a Biomarker of Pro-Atherogenic Phenotype?Jeffrey W Meeusen
The Journal of Applied Laboratory Medicine|February 27, 2021
Spotlight on Laboratory Medicine: A Call for ReflectionsJeffrey W Meeusen
Clinical Chemistry|February 27, 2020
The Heart Attack Cure: Vaccinating Against Cardiovascular DiseaseJeffrey W Meeusen
The Journal of Applied Laboratory Medicine|February 17, 2024
Clinical Impacts of Implementing the 2021 Race-Free Chronic Kidney Disease Epidemiology Collaboration Estimated Glomerular Filtration RateQian Wang, Jeffrey W Meeusen
Clinical Chemistry|October 29, 2022
Ceramide Risk Scores Can Bring Lipidomics to Clinical MedicinePaola Ramos, Jeffrey W Meeusen
The Lancet. Healthy Longevity|September 13, 2022
A more accessible lipid phenotype for predicting type 2 diabetesPaola A Ramos, Jeffrey W Meeusen
Clinical Chemistry|February 28, 2014
Looking for a better creatinineJeffrey W Meeusen, John C Lieske
Clinical Chemistry|August 5, 2021
Has Noninvasive Kidney Transplant Surveillance Finally Arrived?Jeffrey W Meeusen, Hatem Amer, John C Lieske
Pageof 7

Showing results (1-10 of 67) with videos related to

Sort By:
Pageof 7
Clinical Chemistry|February 27, 2020
Apolipoprotein B or Low-Density Lipoprotein Cholesterol: Is It Time for a Twenty-First-Century Lipid Marker?Jeffrey W Meeusen
Clinical Chemistry|January 6, 2018
Comparing Measures of HDL: On the Right Path with the Wrong MapJeffrey W Meeusen
Clinical Chemistry|June 8, 2021
Is Small Dense LDL a Highly Atherogenic Lipid or a Biomarker of Pro-Atherogenic Phenotype?Jeffrey W Meeusen
The Journal of Applied Laboratory Medicine|February 27, 2021
Spotlight on Laboratory Medicine: A Call for ReflectionsJeffrey W Meeusen
Clinical Chemistry|February 27, 2020
The Heart Attack Cure: Vaccinating Against Cardiovascular DiseaseJeffrey W Meeusen
The Journal of Applied Laboratory Medicine|February 17, 2024
Clinical Impacts of Implementing the 2021 Race-Free Chronic Kidney Disease Epidemiology Collaboration Estimated Glomerular Filtration RateQian Wang, Jeffrey W Meeusen
Clinical Chemistry|October 29, 2022
Ceramide Risk Scores Can Bring Lipidomics to Clinical MedicinePaola Ramos, Jeffrey W Meeusen
The Lancet. Healthy Longevity|September 13, 2022
A more accessible lipid phenotype for predicting type 2 diabetesPaola A Ramos, Jeffrey W Meeusen
Clinical Chemistry|February 28, 2014
Looking for a better creatinineJeffrey W Meeusen, John C Lieske
Clinical Chemistry|August 5, 2021
Has Noninvasive Kidney Transplant Surveillance Finally Arrived?Jeffrey W Meeusen, Hatem Amer, John C Lieske
Pageof 7